Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.

Hegde VL, Hegde S, Cravatt BF, Hofseth LJ, Nagarkatti M, Nagarkatti PS.

Mol Pharmacol. 2008 Jul;74(1):20-33. doi: 10.1124/mol.108.047035. Epub 2008 Apr 3.

2.

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells.

Lee CY, Wey SP, Liao MH, Hsu WL, Wu HY, Jan TR.

Int Immunopharmacol. 2008 May;8(5):732-40. doi: 10.1016/j.intimp.2008.01.018. Epub 2008 Feb 14.

PMID:
18387516
3.

Current management of pain associated with multiple sclerosis.

Pöllmann W, Feneberg W.

CNS Drugs. 2008;22(4):291-324. Review.

PMID:
18336059
4.

Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells.

Singh NP, Nagarkatti M, Nagarkatti P.

Mol Pharmacol. 2008 Jun;73(6):1722-35. doi: 10.1124/mol.107.043406. Epub 2008 Mar 11.

5.

Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.

Klein TW, Cabral GA.

J Neuroimmune Pharmacol. 2006 Mar;1(1):50-64. Review.

PMID:
18040791
6.
7.

Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Rajesh M, Pan H, Mukhopadhyay P, Bátkai S, Osei-Hyiaman D, Haskó G, Liaudet L, Gao B, Pacher P.

J Leukoc Biol. 2007 Dec;82(6):1382-9. Epub 2007 Jul 25.

8.
9.

Cannabinoid receptors as novel targets for the treatment of melanoma.

Blázquez C, Carracedo A, Barrado L, Real PJ, Fernández-Luna JL, Velasco G, Malumbres M, Guzmán M.

FASEB J. 2006 Dec;20(14):2633-5. Epub 2006 Oct 25.

PMID:
17065222
10.

Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.

Jia W, Hegde VL, Singh NP, Sisco D, Grant S, Nagarkatti M, Nagarkatti PS.

Mol Cancer Res. 2006 Aug;4(8):549-62.

11.

Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection.

Lu T, Newton C, Perkins I, Friedman H, Klein TW.

J Pharmacol Exp Ther. 2006 Oct;319(1):269-76. Epub 2006 Jul 12.

12.

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.

McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, Nagarkatti M.

Mol Pharmacol. 2006 Sep;70(3):897-908. Epub 2006 Jun 5.

13.

The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.

Herrera B, Carracedo A, Diez-Zaera M, Gómez del Pulgar T, Guzmán M, Velasco G.

Exp Cell Res. 2006 Jul 1;312(11):2121-31. Epub 2006 Apr 19.

PMID:
16624285
14.

Cannabinoid receptors as therapeutic targets.

Mackie K.

Annu Rev Pharmacol Toxicol. 2006;46:101-22. Review.

PMID:
16402900
15.

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

Croxford JL, Yamamura T.

J Neuroimmunol. 2005 Sep;166(1-2):3-18. Review.

PMID:
16023222
17.
19.
20.

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN.

Di Filippo C, Rossi F, Rossi S, D'Amico M.

J Leukoc Biol. 2004 Mar;75(3):453-9. Epub 2003 Dec 4.

PMID:
14657208

Supplemental Content

Support Center